These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25416660)

  • 1. Role of sodium restriction and diuretic therapy for "resistant" hypertension in chronic kidney disease.
    Sinnakirouchenan R; Kotchen TA
    Semin Nephrol; 2014; 34(5):514-9. PubMed ID: 25416660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diuretic agent].
    Hirama A; Tsuruoka S
    Nihon Rinsho; 2014 Aug; 72(8):1472-6. PubMed ID: 25167755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The double challenge of resistant hypertension and chronic kidney disease.
    Rossignol P; Massy ZA; Azizi M; Bakris G; Ritz E; Covic A; Goldsmith D; Heine GH; Jager KJ; Kanbay M; Mallamaci F; Ortiz A; Vanholder R; Wiecek A; Zoccali C; London GM; Stengel B; Fouque D; ; ;
    Lancet; 2015 Oct; 386(10003):1588-98. PubMed ID: 26530623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and Management of Resistant Hypertension.
    Braam B; Taler SJ; Rahman M; Fillaus JA; Greco BA; Forman JP; Reisin E; Cohen DL; Saklayen MG; Hedayati SS
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):524-535. PubMed ID: 27895136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a preferred diuretic class for patients with renal impairment and hypertension?
    Izzo JL; Tobe SW
    J Am Soc Hypertens; 2016 Apr; 10(4):282-4. PubMed ID: 26979914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M; Bellone JM; Wright BM; Rutecki GW
    Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome?
    Vemulapalli S; Tyson CC; Svetkey LP
    Adv Chronic Kidney Dis; 2014 Nov; 21(6):489-99. PubMed ID: 25443574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rational use of diuretics in the treatment of arterial hypertension.
    Mroczek WJ
    Angiology; 1976 Jun; 27(6):358-69. PubMed ID: 1053479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diuretic therapy in congestive heart failure--new views on spironolactone therapy].
    Haller C
    Ther Umsch; 2000 Jun; 57(6):374-9. PubMed ID: 10894022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison.
    Wolley MJ; Stowasser M
    Curr Hypertens Rep; 2016 Apr; 18(5):36. PubMed ID: 27072829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt, the renin-angiotensin-aldosterone system and resistant hypertension.
    Shimosawa T
    Hypertens Res; 2013 Aug; 36(8):657-60. PubMed ID: 23912973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of resistant hypertension in chronic kidney disease.
    Campese VM
    Semin Nephrol; 2014; 34(5):571-6. PubMed ID: 25416666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current options for the treatment of resistant hypertension.
    Ahmed MI; Pisoni R; Calhoun DA
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1385-93. PubMed ID: 19900021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone and volume management in hypertensive heart disease.
    Sica DA
    Semin Nephrol; 2014 May; 34(3):323-32. PubMed ID: 25016402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazide diuretics in advanced chronic kidney disease.
    Agarwal R; Sinha AD
    J Am Soc Hypertens; 2012; 6(5):299-308. PubMed ID: 22951101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.
    Slagman MC; Waanders F; Vogt L; Damman K; Hemmelder M; Navis G; Laverman GD
    Nephrol Dial Transplant; 2012 Mar; 27(3):983-90. PubMed ID: 21862455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in chronic kidney disease-treatment standard 2023.
    Georgianos PI; Agarwal R
    Nephrol Dial Transplant; 2023 Nov; 38(12):2694-2703. PubMed ID: 37355779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hypertension in chronic kidney disease].
    Jędras M; Sawicka M
    Wiad Lek; 2014; 67(3):402-4. PubMed ID: 25782198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and management of the patient with difficult-to-control or resistant hypertension.
    Viera AJ; Hinderliter AL
    Am Fam Physician; 2009 May; 79(10):863-9. PubMed ID: 19496385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.